person · Reporting owner

McCoy Sherilyn S

Disclosed activity across 6 companies

Tapewire entity: 12939
SEC CIK: 0001422968

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
AVON PRODUCTS INCAVP · Entity 152510	Director · CEO	April 23, 2017	April 25, 2017
Certara, Inc.CERT · Entity 787	Director	May 18, 2021	May 18, 2021
JOHNSON & JOHNSONJNJ · Entity 2722	Member, Executive Committee	February 09, 2012	February 13, 2012
KIMBERLY CLARK CORPKMB · Entity 3103	Director	January 02, 2026	January 05, 2026
NovoCure LtdNVCR · Entity 4494	Director	June 09, 2021	June 11, 2021
STRYKER CORPSYK · Entity 369	Director	May 06, 2026	May 08, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

AVON PRODUCTS INC

Report date April 23, 2017 · Filed April 25, 2017

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	658,687	Ending reported balance After 2017-04-24 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2017-04-23 · Exercise / conversion · Acquired 40,000 · Balance 677,439 F1: Restricted stock units vested on April 23, 2017 and 40,000 shares were delivered in settlement of such units. Row 2 · 2017-04-24 · Tax withholding · Disposed 18,752 · Balance 658,687
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2017-04-23 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2017-04-23 · Exercise / conversion · Disposed 40,000 · Balance 0 F1: Restricted stock units vested on April 23, 2017 and 40,000 shares were delivered in settlement of such units. F2: Units correspond 1-for-1 with common stock.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted stock units vested on April 23, 2017 and 40,000 shares were delivered in settlement of such units.

F2: Units correspond 1-for-1 with common stock.

Certara, Inc.

Report date May 18, 2021 · Filed May 18, 2021

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	621,143	Reported balance After 2021-05-18 transaction · row 1 1 source row Row 1 · 2021-05-18 · Grant · Acquired 7,059 · Balance 621,143 F1: Represents 7,059 restricted stock units ("RSU") granted under the Certara Inc. 2020 Incentive Plan that will entitle the reporting person to receive one share of the Issuer's Common Stock per RSU. The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Company's next annual stockholder meeting.

Filing footnotes · ownership attribution and instrument terms

F1: Represents 7,059 restricted stock units ("RSU") granted under the Certara Inc. 2020 Incentive Plan that will entitle the reporting person to receive one share of the Issuer's Common Stock per RSU. The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Company's next annual stockholder meeting.

JOHNSON & JOHNSON

Report date February 09, 2012 · Filed February 13, 2012

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	56,307	Ending reported balance After 2012-02-09 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2012-02-09 · Exercise / conversion · Acquired 7,715 · Balance 59,883 Row 2 · 2012-02-09 · Tax withholding · Disposed 3,576 · Balance 56,307
Common StockSEC Table I · non-derivative	IndirectJohnson & Johnson Stock Fund under the 401(k) Savings Plan	6,455	Reported balance After 2012-01-31 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 3 · 2012-01-31 · Other · Acquired 38 · Balance 6,455 F1: Shares acquired in the Johnson & Johnson Stock Fund under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (1/31/2012).
Common StockSEC Table I · non-derivative	IndirectESOP under the 401(k) Savings Plan	1,316	Reported balance Holding disclosure · report date 2012-02-09 · row 4 Holding and transaction disclosures are not merged. 1 source row Row 4 · Balance 1,316 F2: Shares held by ESOP under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (1/31/2012).
Common StockSEC Table I · non-derivative	IndirectBy Husband	17,292	Reported balance Holding disclosure · report date 2012-02-09 · row 5 Holding and transaction disclosures are not merged. 1 source row Row 5 · Balance 17,292 F3: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: Shares acquired in the Johnson & Johnson Stock Fund under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (1/31/2012).

F2: Shares held by ESOP under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (1/31/2012).

F3: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

KIMBERLY CLARK CORP

Report date January 02, 2026 · Filed January 05, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Restricted Share UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	15,036	Reported balance After 2026-01-02 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-01-02 · Grant · Acquired 2,219 · Balance 15,036 F1: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F2: Includes restricted share units which were accrued based on dividends paid on the Corporation's common stock.

Filing footnotes · ownership attribution and instrument terms

F1: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.

F2: Includes restricted share units which were accrued based on dividends paid on the Corporation's common stock.

NovoCure Ltd

Report date June 09, 2021 · Filed June 11, 2021

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Restricted Stock UnitsSEC Table I · non-derivative	Direct	6,714	Reported balance After 2021-06-09 transaction · row 1 1 source row Row 1 · 2021-06-09 · Grant · Acquired 814 · Balance 6,714 F1: These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (1) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2022 annual general meeting of shareholders.
Options to Buy Ordinary SharesSEC Table II · derivative / convertible security · Conversion / exercise price $211.89 · Expires 2031-06-09	Direct	1,499	Reported balance After 2021-06-09 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2021-06-09 · Grant · Acquired 1,499 · Balance 1,499 F2: Options to buy 1,499 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2022 annual general meeting of shareholders.

Filing footnotes · ownership attribution and instrument terms

F1: These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (1) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2022 annual general meeting of shareholders.

F2: Options to buy 1,499 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2022 annual general meeting of shareholders.

STRYKER CORP

Report date May 06, 2026 · Filed May 08, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	7,190	Reported balance After 2026-05-06 transaction · row 1 1 source row Row 1 · 2026-05-06 · Grant · Acquired 762 · Balance 7,190 F1: Represents a grant of Restricted Stock Units (RSUs), which vest as to 100% of the shares on the earlier of (i) the date of the 2027 Annual Meeting of Shareholders of Stryker Corporation or (ii) May 6, 2027. The Reporting Person voluntarily elected to defer receipt of the shares of Stryker Common Stock issuable upon settlement of the RSUs until May 1, 2031. F2: Each RSU represents a contingent right to receive one share of Stryker Common Stock.

Filing footnotes · ownership attribution and instrument terms

F1: Represents a grant of Restricted Stock Units (RSUs), which vest as to 100% of the shares on the earlier of (i) the date of the 2027 Annual Meeting of Shareholders of Stryker Corporation or (ii) May 6, 2027. The Reporting Person voluntarily elected to defer receipt of the shares of Stryker Common Stock issuable upon settlement of the RSUs until May 1, 2031.

F2: Each RSU represents a contingent right to receive one share of Stryker Common Stock.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
May 06, 2026 Filed May 8, 2026 20:45 UTC	STRYKER CORP SYK · Entity 369	GrantCommon Stock	762	$0.00	$0.00	Disclosure SEC source: 0001422968-26-000001 · wk-form4_1778273125.xml · nonDerivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,190 F1 · shares: Represents a grant of Restricted Stock Units (RSUs), which vest as to 100% of the shares on the earlier of (i) the date of the 2027 Annual Meeting of Shareholders of Stryker Corporation or (ii) May 6, 2027. The Reporting Person voluntarily elected to defer receipt of the shares of Stryker Common Stock issuable upon settlement of the RSUs until May 1, 2031. F2 · price: Each RSU represents a contingent right to receive one share of Stryker Common Stock. Read SEC document
January 02, 2026 Filed Jan 5, 2026 22:21 UTC	KIMBERLY CLARK CORP KMB · Entity 3103	GrantRestricted Share Units · Derivative	2,219	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-26-000218 · doc4.xml · derivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,036 Underlying: Common Stock · 2,219 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.exercise_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.expiration_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F2 · balance_after: Includes restricted share units which were accrued based on dividends paid on the Corporation's common stock. Read SEC document
May 08, 2025 Filed May 12, 2025 21:09 UTC	STRYKER CORP SYK · Entity 369	GrantCommon Stock	560	$0.00	$0.00	Disclosure SEC source: 0000310764-25-000079 · wk-form4_1747084179.xml · nonDerivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,428 F1 · shares: Represents a grant of Restricted Stock Units (RSUs), which vest as to 100% of the shares on the earlier of (i) the date of the 2026 Annual Meeting of Shareholders of Stryker Corporation or (ii) May 8, 2026. The Reporting Person voluntarily elected to defer receipt of the shares of Stryker Common Stock issuable upon settlement of the RSUs until May 1, 2030. F2 · price: Each RSU represents a contingent right to receive one share of Stryker Common Stock. Read SEC document
January 02, 2025 Filed Jan 6, 2025 21:38 UTC	KIMBERLY CLARK CORP KMB · Entity 3103	GrantRestricted Share Units · Derivative	1,722	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-25-000355 · doc4.xml · derivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,357.0196 Underlying: Common Stock · 1,722 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.exercise_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.expiration_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F2 · balance_after: Includes restricted share units which were accrued based on dividends paid on the Corporation's common stock. Read SEC document
May 09, 2024 Filed May 13, 2024 22:11 UTC	STRYKER CORP SYK · Entity 369	GrantCommon Stock	653	$0.00	$0.00	Disclosure SEC source: 0000310764-24-000073 · wk-form4_1715638297.xml · nonDerivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,868 F1 · shares: Represents a grant of Restricted Stock Units (RSUs), which vest as to 100% of the shares on the earlier of (i) the date of the 2025 Annual Meeting of Shareholders of Stryker Corporation or (ii) May 9, 2025. The Reporting Person voluntarily elected to defer receipt of the shares of Stryker Common Stock issuable upon settlement of the RSUs until May 1, 2029. F2 · price: Each RSU represents a contingent right to receive one share of Stryker Common Stock. Read SEC document
January 02, 2024 Filed Jan 4, 2024 16:29 UTC	KIMBERLY CLARK CORP KMB · Entity 3103	GrantRestricted Share Units · Derivative	1,716	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-24-000343 · doc4.xml · derivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,270 Underlying: Common Stock · 1,716 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.exercise_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.expiration_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F2 · balance_after: Includes restricted share units which were accrued based on dividends paid on the Corporation's common stock. Read SEC document
May 10, 2023 Filed May 12, 2023 21:40 UTC	STRYKER CORP SYK · Entity 369	GrantCommon Stock	705	$0.00	$0.00	Disclosure SEC source: 0000310764-23-000082 · wf-form4_168392763688871.xml · nonDerivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,215 F1 · shares: Represents a grant of Restricted Stock Units (RSUs), which vest as to 100% of the shares on the earlier of (i) the date of the 2024 Annual Meeting of Shareholders of Stryker Corporation or (ii) May 10, 2024. The Reporting Person voluntarily elected to defer receipt of the shares of Stryker Common Stock issuable upon settlement of the RSUs until May 1, 2028. F2 · price: Each RSU represents a contingent right to receive one share of Stryker Common Stock. Read SEC document
May 04, 2023 Filed May 8, 2023 20:34 UTC	STRYKER CORP SYK · Entity 369	Exercise / conversionRestricted Stock Units granted 05/04/2022 · Derivative	841	$0.00	$0.00	Disclosure SEC source: 0000310764-23-000074 · wf-form4_168357808634845.xml · derivative · entry 2 McCoy Sherilyn S · CIK 0001422968 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 841 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Stryker Common Stock. F1 · derivative.exercise_date: On May 4, 2023, 841 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.expiration_date: On May 4, 2023, 841 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. Read SEC document
May 04, 2023 Filed May 8, 2023 20:34 UTC	STRYKER CORP SYK · Entity 369	Exercise / conversionCommon Stock	841	$0.00	$0.00	Disclosure SEC source: 0000310764-23-000074 · wf-form4_168357808634845.xml · nonDerivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On May 4, 2023, 841 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F2 · balance_after: The reporting person has previously reported awards of Restricted Stock Units in Table II of Form 4. The total reported in column 5 includes 3,669 Restricted Stock Units previously reported in Table II, for which vesting has been voluntarily deferred until a later date. Read SEC document
January 03, 2023 Filed Jan 4, 2023 23:26 UTC	KIMBERLY CLARK CORP KMB · Entity 3103	GrantRestricted Share Units · Derivative	1,495	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-23-000323 · doc4.xml · derivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,268 Underlying: Common Stock · 1,495 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.exercise_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.expiration_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F2 · balance_after: Includes restricted share units which were accrued based on dividends paid on the Corporation's common stock. Read SEC document
May 04, 2022 Filed May 6, 2022 18:36 UTC	STRYKER CORP SYK · Entity 369	GrantRestricted Stock Units granted 05/04/2022 · Derivative	841	$0.00	$0.00	Disclosure SEC source: 0000310764-22-000071 · wf-form4_165186218815073.xml · derivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 841 Underlying: Common Stock · 841 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Stryker Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest as to 100% of the shares on the earlier of (i) the date of the 2023 Annual Meeting of Shareholders of Stryker Corporation or (ii) May 4, 2023. F2 · derivative.expiration_date: The Restricted Stock Units vest as to 100% of the shares on the earlier of (i) the date of the 2023 Annual Meeting of Shareholders of Stryker Corporation or (ii) May 4, 2023. Read SEC document
January 03, 2022 Filed Jan 5, 2022 18:18 UTC	KIMBERLY CLARK CORP KMB · Entity 3103	GrantRestricted Share Units · Derivative	1,439	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-22-000400 · doc4.xml · derivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,548 Underlying: Common Stock · 1,439 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.exercise_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.expiration_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F2 · balance_after: Includes restricted share units which were accrued based on dividends paid on the Corporation's common stock. Read SEC document
June 09, 2021 Filed Jun 11, 2021 20:24 UTC	NovoCure Ltd NVCR · Entity 4494	GrantOptions to Buy Ordinary Shares · Derivative	1,499	$0.00 Strike: $211.89	$0.00	Disclosure SEC source: 0001645113-21-000079 · wf-form4_162344303527240.xml · derivative · entry 2 McCoy Sherilyn S · CIK 0001422968 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,499 Underlying: Ordinary Shares · 1,499 shares Expires 2031-06-09 F2 · derivative.exercise_date: Options to buy 1,499 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2022 annual general meeting of shareholders. Read SEC document
June 09, 2021 Filed Jun 11, 2021 20:24 UTC	NovoCure Ltd NVCR · Entity 4494	GrantRestricted Stock Units	814	$0.00	$0.00	Disclosure SEC source: 0001645113-21-000079 · wf-form4_162344303527240.xml · nonDerivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,714 F1 · shares: These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (1) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2022 annual general meeting of shareholders. Read SEC document
May 18, 2021 Filed May 18, 2021 20:49 UTC	Certara, Inc. CERT · Entity 787	GrantCommon Stock	7,059	$0.00	$0.00	Disclosure SEC source: 0001104659-21-068893 · tm2116784-2_4seq1.xml · nonDerivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 621,143 F1 · kind: Represents 7,059 restricted stock units ("RSU") granted under the Certara Inc. 2020 Incentive Plan that will entitle the reporting person to receive one share of the Issuer's Common Stock per RSU. The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Company's next annual stockholder meeting. Read SEC document
May 05, 2021 Filed May 7, 2021 21:46 UTC	STRYKER CORP SYK · Entity 369	GrantRestricted Stock Units granted 05/05/2021 · Derivative	693	$0.00	$0.00	Disclosure SEC source: 0000310764-21-000088 · wf-form4_162042396384277.xml · derivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 693 Underlying: Common Stock · 693 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Stryker Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest as to 100% of the shares on the earlier of (i) the date of the 2022 Annual Meeting of Shareholders of Stryker Corporation or (ii) May 5, 2022. F2 · derivative.expiration_date: The Restricted Stock Units vest as to 100% of the shares on the earlier of (i) the date of the 2022 Annual Meeting of Shareholders of Stryker Corporation or (ii) May 5, 2022. Read SEC document
January 04, 2021 Filed Jan 6, 2021 18:39 UTC	KIMBERLY CLARK CORP KMB · Entity 3103	GrantRestricted Share Units · Derivative	1,349	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-21-000482 · doc4.xml · derivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,952.9707 Underlying: Common Stock · 1,349 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.exercise_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.expiration_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F2 · balance_after: Includes restricted share units which were accrued based on dividends paid on the Corporation's common stock. Read SEC document
June 10, 2020 Filed Jun 12, 2020 22:03 UTC	NovoCure Ltd NVCR · Entity 4494	GrantOptions to Buy Ordinary Shares · Derivative	5,101	$0.00 Strike: $67.89	$0.00	Disclosure SEC source: 0001645113-20-000086 · wf-form4_159199941976503.xml · derivative · entry 2 McCoy Sherilyn S · CIK 0001422968 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,101 Underlying: Ordinary Shares · 5,101 shares Expires 2030-06-10 F2 · derivative.exercise_date: Options to buy 5,101 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2021 annual general meeting of shareholders. Read SEC document
June 10, 2020 Filed Jun 12, 2020 22:03 UTC	NovoCure Ltd NVCR · Entity 4494	GrantRestricted Stock Units	2,541	$0.00	$0.00	Disclosure SEC source: 0001645113-20-000086 · wf-form4_159199941976503.xml · nonDerivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,900 F1 · shares: These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (1) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2021 annual general meeting of shareholders. Read SEC document
January 02, 2020 Filed Jan 3, 2020 20:14 UTC	KIMBERLY CLARK CORP KMB · Entity 3103	GrantRestricted Share Units · Derivative	1,325	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-20-000200 · doc4.xml · derivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,505.7716 Underlying: Common Stock · 1,325 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.exercise_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.expiration_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. Read SEC document
May 22, 2019 Filed May 24, 2019 20:20 UTC	NovoCure Ltd NVCR · Entity 4494	GrantOptions to Buy Ordinary Shares · Derivative	6,340	$0.00 Strike: $51.36	$0.00	Disclosure SEC source: 0001209191-19-032709 · doc4.xml · derivative · entry 2 McCoy Sherilyn S · CIK 0001422968 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,340 Underlying: Ordinary Shares · 6,340 shares Expires 2029-05-22 F2 · derivative.exercise_date: Options to buy 6,340 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2020 annual general meeting of shareholders. Read SEC document
May 22, 2019 Filed May 24, 2019 20:20 UTC	NovoCure Ltd NVCR · Entity 4494	GrantRestricted Stock Units	3,359	$0.00	$0.00	Disclosure SEC source: 0001209191-19-032709 · doc4.xml · nonDerivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,359 F1 · shares: These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2020 annual general meeting of shareholders. Read SEC document
May 01, 2019 Filed May 3, 2019 00:56 UTC	STRYKER CORP SYK · Entity 369	GrantRestricted Stock Units granted 05/01/2019 · Derivative	937	$0.00	$0.00	Disclosure SEC source: 0000310764-19-000087 · wf-form4_155684497058513.xml · derivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 937 Underlying: Common Stock · 937 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Stryker Common Stock. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Stryker Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest as to 100% of the shares on the earlier of (i) the date of the 2020 Annual Meeting of Shareholders of Stryker Corporation or (ii) May 1, 2020. F2 · derivative.expiration_date: The Restricted Stock Units vest as to 100% of the shares on the earlier of (i) the date of the 2020 Annual Meeting of Shareholders of Stryker Corporation or (ii) May 1, 2020. Read SEC document
January 02, 2019 Filed Jan 3, 2019 21:15 UTC	KIMBERLY CLARK CORP KMB · Entity 3103	GrantRestricted Share Units · Derivative	1,610	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-19-000361 · doc4.xml · derivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,126 Underlying: Common Stock · 1,610 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.exercise_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.expiration_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. Read SEC document
September 12, 2018 Filed Sep 14, 2018 15:34 UTC	KIMBERLY CLARK CORP KMB · Entity 3103	GrantRestricted Share Units · Derivative	516	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001225208-18-013394 · doc4.xml · derivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 516 Underlying: Common Stock · 516 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.exercise_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.expiration_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. Read SEC document
May 31, 2018 Filed Jun 5, 2018 00:17 UTC	NovoCure Ltd NVCR · Entity 4494	GrantOptions to Buy Ordinary Shares · Derivative	45,137	$0.00 Strike: $31.45	$0.00	Disclosure SEC source: 0001209191-18-035384 · doc4.xml · derivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,137 Underlying: Ordinary Shares · 45,137 shares Expires 2028-05-31 F1 · derivative.exercise_date: This stock option will vest in equal parts on the earlier of each of the following dates: (i) the first, second and third anniversary of the grant date and (ii) the day immediately preceding of the Company's 2019, 2020 and 2021 annual general meeting of shareholders, respectively. Read SEC document
May 02, 2018 Filed May 4, 2018 18:16 UTC	STRYKER CORP SYK · Entity 369	GrantRestricted Stock Units granted 05/02/2018 · Derivative	1,048	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000310764-18-000146 · wf-form4_152545774784441.xml · derivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,048 Underlying: Common Stock · 1,048 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Stryker common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Stryker common stock. F2 · derivative.exercise_date: The Restricted Stock Units vest as to 100% of the shares on the earlier of (i) the date of the 2019 Annual Meeting of Shareholders of Stryker Corporation or (ii) May 2, 2019. F2 · derivative.expiration_date: The Restricted Stock Units vest as to 100% of the shares on the earlier of (i) the date of the 2019 Annual Meeting of Shareholders of Stryker Corporation or (ii) May 2, 2019. Read SEC document
April 24, 2017 Filed Apr 25, 2017 17:32 UTC	AVON PRODUCTS INC AVP · Entity 152510	Tax withholdingCommon Stock	18,752	$4.40	$82,508.80	Disclosure SEC source: 0001209191-17-028152 · doc4.xml · nonDerivative · entry 2 McCoy Sherilyn S · CIK 0001422968 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 658,687 Read SEC document
April 23, 2017 Filed Apr 25, 2017 17:32 UTC	AVON PRODUCTS INC AVP · Entity 152510	Exercise / conversionRestricted Stock Units · Derivative	40,000	$0.00	$0.00	Disclosure SEC source: 0001209191-17-028152 · doc4.xml · derivative · entry 3 McCoy Sherilyn S · CIK 0001422968 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Restricted stock units vested on April 23, 2017 and 40,000 shares were delivered in settlement of such units. F2 · derivative.exercise_price: Units correspond 1-for-1 with common stock. F1 · derivative.exercise_date: Restricted stock units vested on April 23, 2017 and 40,000 shares were delivered in settlement of such units. F1 · derivative.expiration_date: Restricted stock units vested on April 23, 2017 and 40,000 shares were delivered in settlement of such units. Read SEC document
April 23, 2017 Filed Apr 25, 2017 17:32 UTC	AVON PRODUCTS INC AVP · Entity 152510	Exercise / conversionCommon Stock	40,000	$0.00	$0.00	Disclosure SEC source: 0001209191-17-028152 · doc4.xml · nonDerivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 677,439 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units vested on April 23, 2017 and 40,000 shares were delivered in settlement of such units. Read SEC document
March 17, 2017 Filed Mar 21, 2017 19:45 UTC	AVON PRODUCTS INC AVP · Entity 152510	GrantStock Option (Right to Buy) · Derivative	1,386,000	$0.00 Strike: $5.54	$0.00	Disclosure SEC source: 0001209191-17-022132 · doc4.xml · derivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,386,000 Underlying: Common Stock · 1,386,000 shares Expires 2027-03-17 F1 · derivative.exercise_price: The exercise price of this premium-priced stock option is equal to 125% of the closing price of Avon's common stock on the date of grant. F2 · derivative.exercise_date: This option vests in three equal annual installments beginning on 03/17/2018. Read SEC document
March 13, 2017 Filed Mar 15, 2017 19:36 UTC	AVON PRODUCTS INC AVP · Entity 152510	Tax withholdingCommon Stock	223,007	$4.31	$961,160.17	Disclosure SEC source: 0001209191-17-020930 · doc4.xml · nonDerivative · entry 2 McCoy Sherilyn S · CIK 0001422968 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 637,439 Read SEC document
March 13, 2017 Filed Mar 15, 2017 19:36 UTC	AVON PRODUCTS INC AVP · Entity 152510	GrantCommon Stock	475,696	$0.00	$0.00	Disclosure SEC source: 0001209191-17-020930 · doc4.xml · nonDerivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 860,446 F1 · security: Represents 475,696 shares of common stock delivered in connection with the vesting of performance-based restricted stock units based on the achievement of certain performance targets for the 2014-2016 performance period. F1 · price: Represents 475,696 shares of common stock delivered in connection with the vesting of performance-based restricted stock units based on the achievement of certain performance targets for the 2014-2016 performance period. Read SEC document
December 30, 2016 Filed Jan 4, 2017 16:53 UTC	AVON PRODUCTS INC AVP · Entity 152510	Tax withholdingCommon Stock	87,394	$5.05	$441,339.70	Disclosure SEC source: 0001209191-17-001090 · doc4.xml · nonDerivative · entry 2 McCoy Sherilyn S · CIK 0001422968 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 384,750 Read SEC document
December 30, 2016 Filed Jan 4, 2017 16:53 UTC	AVON PRODUCTS INC AVP · Entity 152510	GrantCommon Stock	169,465	$0.00	$0.00	Disclosure SEC source: 0001209191-17-001090 · doc4.xml · nonDerivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 472,144 F1 · security: Represents 169,465 shares of common stock delivered in connection with the vesting of performance-based restricted stock units based on the achievement of certain performance targets for the 2015 performance period. F1 · price: Represents 169,465 shares of common stock delivered in connection with the vesting of performance-based restricted stock units based on the achievement of certain performance targets for the 2015 performance period. Read SEC document
February 09, 2012 Filed Feb 13, 2012 23:44 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	Tax withholdingCommon Stock	3,576	$65.09	$232,761.84	Disclosure SEC source: 0000200406-12-000023 · edgar.xml · nonDerivative · entry 2 McCoy Sherilyn S · CIK 0001422968 · Member, Executive Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,307 Read SEC document
February 09, 2012 Filed Feb 13, 2012 23:44 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	Exercise / conversionCommon Stock	7,715	$0.00	$0.00	Disclosure SEC source: 0000200406-12-000023 · edgar.xml · nonDerivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Member, Executive Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,883 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
January 31, 2012 Filed Feb 13, 2012 23:44 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	OtherCommon Stock	38	Not disclosed	Not disclosed	Disclosure SEC source: 0000200406-12-000023 · edgar.xml · nonDerivative · entry 3 McCoy Sherilyn S · CIK 0001422968 · Member, Executive Committee 10b5-1 filing: Not disclosed Ownership: Indirect · Johnson & Johnson Stock Fund under the 401(k) Savings Plan Disclosed balance after: 6,455 F1 · security: Shares acquired in the Johnson & Johnson Stock Fund under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (1/31/2012). F1 · price: Shares acquired in the Johnson & Johnson Stock Fund under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (1/31/2012). Read SEC document
January 17, 2012 Filed Jan 19, 2012 23:51 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	GrantPerformance Share Units · Derivative	42,112	$0.00	$0.00	Disclosure SEC source: 0000200406-12-000014 · edgar.xml · derivative · entry 7 McCoy Sherilyn S · CIK 0001422968 · Member, Executive Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,112 Underlying: Common Stock · 42,112 shares Expires not disclosed F5 · security: Awarded under Issuer's Long-Term Incentive Plan. F8 · derivative.exercise_price: Each Performance Share Unit converts into one share of Common Stock upon distribution in the first quarter of 2015 based on a performance factor. F8 · derivative.exercise_date: Each Performance Share Unit converts into one share of Common Stock upon distribution in the first quarter of 2015 based on a performance factor. F8 · derivative.expiration_date: Each Performance Share Unit converts into one share of Common Stock upon distribution in the first quarter of 2015 based on a performance factor. Read SEC document
January 17, 2012 Filed Jan 19, 2012 23:51 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	GrantRestricted Share Units · Derivative	16,845	$0.00	$0.00	Disclosure SEC source: 0000200406-12-000014 · edgar.xml · derivative · entry 6 McCoy Sherilyn S · CIK 0001422968 · Member, Executive Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,845 Underlying: Common Stock · 16,845 shares Expires not disclosed F5 · security: Awarded under Issuer's Long-Term Incentive Plan. F6 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one share of Common Stock. F7 · derivative.expiration_date: The Restricted Share Units vest three years after date of grant. Read SEC document
January 17, 2012 Filed Jan 19, 2012 23:51 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	GrantEmployee Stock Option (Right to Buy) · Derivative	231,951	$0.00 Strike: $65.37	$0.00	Disclosure SEC source: 0000200406-12-000014 · edgar.xml · derivative · entry 5 McCoy Sherilyn S · CIK 0001422968 · Member, Executive Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,951 Underlying: Common Stock · 231,951 shares Expires 2022-01-17 F5 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document
January 17, 2012 Filed Jan 19, 2012 23:51 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	GrantCommon Stock	2,925	Not disclosed	Not disclosed	Disclosure SEC source: 0000200406-12-000014 · edgar.xml · nonDerivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Member, Executive Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,168 F1 · price: Awarded under Issuer's Executive Incentive Plan. Read SEC document
December 31, 2011 Filed Jan 19, 2012 23:51 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	OtherCommon Stock	66	Not disclosed	Not disclosed	Disclosure SEC source: 0000200406-12-000014 · edgar.xml · nonDerivative · entry 2 McCoy Sherilyn S · CIK 0001422968 · Member, Executive Committee 10b5-1 filing: Not disclosed Ownership: Indirect · Johnson & Johnson Stock Fund under the 401(k) Savings Plan Disclosed balance after: 6,417 F2 · security: Shares acquired in the Johnson & Johnson Stock Fund under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (12/31/2011). F2 · price: Shares acquired in the Johnson & Johnson Stock Fund under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (12/31/2011). Read SEC document
November 15, 2011 Filed Nov 17, 2011 15:05 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative	21,000	$0.00 Strike: $57.30	$0.00	Disclosure SEC source: 0000200406-11-000117 · edgar.xml · derivative · entry 6 McCoy Sherilyn S · CIK 0001422968 · Member, Executive Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,000 shares Expires 2012-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant. Read SEC document
November 15, 2011 Filed Nov 17, 2011 15:05 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	SaleCommon Stock	21,000	$65.00	$1,365,000.00	Disclosure SEC source: 0000200406-11-000117 · edgar.xml · nonDerivative · entry 2 McCoy Sherilyn S · CIK 0001422968 · Member, Executive Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,243 Read SEC document
November 15, 2011 Filed Nov 17, 2011 15:05 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	Exercise / conversionCommon Stock	21,000	$57.30	$1,203,300.00	Disclosure SEC source: 0000200406-11-000117 · edgar.xml · nonDerivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Member, Executive Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,243 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
October 30, 2011 Filed Nov 17, 2011 15:05 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	OtherCommon Stock	341	Not disclosed	Not disclosed	Disclosure SEC source: 0000200406-11-000117 · edgar.xml · nonDerivative · entry 3 McCoy Sherilyn S · CIK 0001422968 · Member, Executive Committee 10b5-1 filing: Not disclosed Ownership: Indirect · Johnson & Johnson Stock Fund under the 401(k) Savings Plan Disclosed balance after: 6,351 F1 · security: Shares acquired in the Johnson & Johnson Stock Fund under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (10/30/2011). F1 · price: Shares acquired in the Johnson & Johnson Stock Fund under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (10/30/2011). Read SEC document
January 10, 2011 Filed Jan 12, 2011 22:59 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	GrantRestricted Share Units · Derivative	12,635	$0.00	$0.00	Disclosure SEC source: 0000200406-11-000014 · edgar.xml · derivative · entry 6 McCoy Sherilyn S · CIK 0001422968 · Member, Executive Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,635 Underlying: Common Stock · 12,635 shares Expires not disclosed F5 · security: Awarded under Issuer's Long-Term Incentive Plan. F6 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock. F7 · derivative.expiration_date: The Restricted Share Units vest three years after date of grant. Read SEC document
January 10, 2011 Filed Jan 12, 2011 22:59 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	GrantEmployee Stock Option (Right to Buy) · Derivative	151,621	$0.00 Strike: $62.20	$0.00	Disclosure SEC source: 0000200406-11-000014 · edgar.xml · derivative · entry 5 McCoy Sherilyn S · CIK 0001422968 · Member, Executive Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,621 Underlying: Common Stock · 151,621 shares Expires 2021-01-10 F5 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document
January 10, 2011 Filed Jan 12, 2011 22:59 UTC	JOHNSON & JOHNSON JNJ · Entity 2722	GrantCommon Stock	2,713	Not disclosed	Not disclosed	Disclosure SEC source: 0000200406-11-000014 · edgar.xml · nonDerivative · entry 1 McCoy Sherilyn S · CIK 0001422968 · Member, Executive Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,243 F1 · price: Awarded under Issuer's Executive Incentive Plan. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.